United States Immunostimulatory Adjuvants Market Report 2021

United States Immunostimulatory Adjuvants Market Report 2021

1 Immunostimulatory Adjuvants Overview

1.1 Product Overview and Scope of Immunostimulatory Adjuvants

1.2 Classification of Immunostimulatory Adjuvants

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Applications of Immunostimulatory Adjuvants

1.3.1 Prostate Cancer

1.3.2 Breast Cancer

1.3.3 Gastric Cancer

1.3.4 Lung Cancer

1.3.5 Pancreatic Cancer

1.4 USA Market Size (Value and Volume) of Immunostimulatory Adjuvants (2011-2021)

1.4.1 USA Immunostimulatory Adjuvants Sales, Revenue and Price (2011-2021)

1.4.2 USA Immunostimulatory Adjuvants Sales and Growth Rate (2011-2021)

1.4.3 USA Immunostimulatory Adjuvants Revenue and Growth Rate (2011-2021)

2 USA Immunostimulatory Adjuvants Competition by Manufacturers

2.1 USA Immunostimulatory Adjuvants Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Immunostimulatory Adjuvants Revenue and Share by Manufactures (2015 and 2016)

3 USA Immunostimulatory Adjuvants (Volume and Value) by Type

3.1 USA Immunostimulatory Adjuvants Sales and Market Share by Type (2011-2021)

3.2 USA Immunostimulatory Adjuvants Revenue and Market Share by Type (2011-2021)

4 USA Immunostimulatory Adjuvants (Volume) by Application

5 USA Immunostimulatory Adjuvants Manufacturers Analysis

5.1 AFFiRiS

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Immunostimulatory Adjuvants Product Type and Technology

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Immunostimulatory Adjuvants Sales, Revenue, Price of AFFiRiS (2015 and 2016)

5.2 AlerGenetica

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharma & Healthcare Product Type and Technology

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Pharma & Healthcare Sales, Revenue, Price of AlerGenetica (2015 and 2016)

5.3 Anergis

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Anergis Product Type and Technology

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Anergis Sales, Revenue, Price of Anergis (2015 and 2016)

5.4 Antigen Express

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Bionor Pharma Product Type and Technology

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Antigen Express Sales, Revenue, Price of Antigen Express (2015 and 2016)

5.5 Apitope Technology

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Apitope Technology Product Type and Technology

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Apitope Technology Sales, Revenue, Price of Apitope Technology (2015 and 2016)

5.6 Araclon Biotech

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Araclon Biotech Product Type and Technology

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Araclon Biotech Sales, Revenue, Price of Araclon Biotech (2015 and 2016)

5.7 Artificial Cell Technologies

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Artificial Cell Technologies Product Type and Technology

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Artificial Cell Technologies Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)

5.8 Benovus Bio

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Benovus Bio Product Type and Technology

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Benovus Bio Sales, Revenue, Price of Benovus Bio (2015 and 2016)

5.9 Bionor Pharma

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Bionor Pharma Product Type and Technology

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Bionor Pharma Sales, Revenue, Price of Bionor Pharma (2015 and 2016)

5.10 Circassia

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Circassia Product Type and Technology

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Circassia Sales, Revenue, Price of Circassia (2015 and 2016)

5.11 Celgene Corporation

5.12 Galena Biopharma

5.13 Immatics biotechnologies

5.14 Immune Design

5.15 ImmunoCellular Therapeutics

5.16 Invectys

5.17 ISA Pharmaceuticals

5.18 Lytix Biopharma

5.19 Medinet

5.20 Spotlight Innovation (Memcine Pharmaceuticals)

5.21 Merck Serono

5.22 OncoTherapy Science

5.23 Peptech

5.24 Peptinov

5.25 PeptiVir

6 Immunostimulatory Adjuvants Technology and Development Trend

6.1 Immunostimulatory Adjuvants Technology Analysis

6.2 Immunostimulatory Adjuvants Technology Development Trend

7 Research Findings and Conclusion

Figure Picture of Immunostimulatory Adjuvants

Table Classification of Immunostimulatory Adjuvants

Figure USA Sales Market Share of Immunostimulatory Adjuvants by Type in 2015

Table Applications of Immunostimulatory Adjuvants

Figure USA Sales Market Share of Immunostimulatory Adjuvants by Application in 2015

Figure Prostate Cancer Examples

Figure Breast Cancer Examples

Figure Gastric Cancer Examples

Figure Lung Cancer Examples

Figure Pancreatic Cancer Examples

Table USA Immunostimulatory Adjuvants Sales, Revenue and Price (2011-2021)

Figure USA Immunostimulatory Adjuvants Sales and Growth Rate (2011-2021)

Figure USA Immunostimulatory Adjuvants Revenue and Growth Rate (2011-2021)

Table USA Immunostimulatory Adjuvants Sales of Key Manufacturers (2015 and 2016)

Table USA Immunostimulatory Adjuvants Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Immunostimulatory Adjuvants Sales Share by Manufacturers

Figure 2016 Immunostimulatory Adjuvants Sales Share by Manufacturers

Table USA Immunostimulatory Adjuvants Revenue by Manufacturers (2015 and 2016)

Table USA Immunostimulatory Adjuvants Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Immunostimulatory Adjuvants Revenue Share by Manufacturers

Table 2016 USA Immunostimulatory Adjuvants Revenue Share by Manufacturers

Table USA Immunostimulatory Adjuvants Sales and Market Share by Type (2011-2021)

Table USA Immunostimulatory Adjuvants Sales Share by Type (2011-2021)

Figure Sales Market Share of Immunostimulatory Adjuvants by Type (2011-2021)

Figure USA Immunostimulatory Adjuvants Sales Growth Rate by Type (2011-2021)

Table USA Immunostimulatory Adjuvants Revenue and Market Share by Type (2011-2021)

Table USA Immunostimulatory Adjuvants Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Immunostimulatory Adjuvants by Type (2011-2021)

Figure USA Immunostimulatory Adjuvants Revenue Growth Rate by Type (2011-2021)

Table USA Immunostimulatory Adjuvants Sales and Market Share by Application (2011-2021)

Table USA Immunostimulatory Adjuvants Sales Share by Application (2011-2021)

Figure Sales Market Share of Immunostimulatory Adjuvants by Application (2011-2021)

Figure USA Immunostimulatory Adjuvants Sales Growth Rate by Application (2011-2021)

Table AFFiRiS Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of AFFiRiS (2015 and 2016)

Table AlerGenetica Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of AlerGenetica (2015 and 2016)

Table Anergis Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Anergis (2015 and 2016)

Table Antigen Express Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Antigen Express (2015 and 2016)

Table Apitope Technology Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Apitope Technology (2015 and 2016)

Table Araclon Biotech Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Araclon Biotech (2015 and 2016)

Table Artificial Cell Technologies Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)

Table Benovus Bio Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Benovus Bio (2015 and 2016)

Table Bionor Pharma Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Bionor Pharma (2015 and 2016)

Table Circassia Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Circassia (2015 and 2016)

Table Celgene Corporation Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Celgene Corporation (2015 and 2016)

Table Galena Biopharma Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Galena Biopharma (2015 and 2016)

Table Immatics biotechnologies Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Immatics biotechnologies (2015 and 2016)

Table Immune Design Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Immune Design (2015 and 2016)

Table ImmunoCellular Therapeutics Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of ImmunoCellular Therapeutics (2015 and 2016)

Table Invectys Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Invectys (2015 and 2016)

Table ISA Pharmaceuticals Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of ISA Pharmaceuticals (2015 and 2016)

Table Lytix Biopharma Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Lytix Biopharma (2015 and 2016)

Table Medinet Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Medinet (2015 and 2016)

Table Spotlight Innovation (Memcine Pharmaceuticals) Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Spotlight Innovation (Memcine Pharmaceuticals) (2015 and 2016)

Table Merck Serono Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Merck Serono (2015 and 2016)

Table OncoTherapy Science Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of OncoTherapy Science (2015 and 2016)

Table Peptech Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Peptech (2015 and 2016)

Table Peptinov Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of Peptinov (2015 and 2016)

Table PeptiVir Basic Information List

Table Immunostimulatory Adjuvants Sales, Revenue, Price of PeptiVir (2015 and 2016)